INTRODUCTION
Cellulases and hemicellulases expressed by aerobic microorganisms generally have a modular structure in which the catalytic domain is linked to a cellulose-binding domain (CBD) by flexible sequences rich in hydroxy amino acids [1] . Based on primary structure homologies, there are at least ten different types of CBD [2] , with Type I and Type II being the most common domain in aerobic-fungal and bacterial cellulases, respectively.
Recently the three-dimensional structures of Types I, II, III, IV and V CBDs have been determined [3] [4] [5] [6] [7] . These domains consist mainly of β-strands and have very little α-helical structure. The cellulose-binding region of Types I, II, III and V CBDs consists of a planar hydrophobic region on the surface of the domains, in which ligand binding is mediated by hydrophobicstacking interactions between solvent-exposed aromatic residues and the glucosyl-pyranose rings [8, 9] . Rather than binding to cello-oligosaccharides or soluble cellulose, the domains exhibit a strong preference for insoluble forms of the polysaccharide, suggesting that the binding surface interacts with multiple cellulose chains [4, 10] .
Several studies have shown that Types I and II CBDs potentiate the activity of cellulases and xylanases (1,4-β--xylan xylanhydrolase, EC 3.2.1.32) against recalcitrant substrates [11] [12] [13] . The Cellulomonas fimi Type II domains appear to mediate their Abbreviations used : CBD, cellulose-binding domain ; LB, Luria broth ; MUC, methylumbelliferyl-β-D-cellobioside ; Pf Xyn10A, xylanase A from Pseudomonas f luorescens subsp. cellulosa. 1 To whom correspondence should be addressed (e-mail H.Gilbert!Newcastle.ac.uk).
when not covalently linked to the enzyme. There was no substantial difference in the affinity of full-length Pf Xyn10A and the enzyme's Type II CBD for cellulose. Key words : cell-wall breakdown, cellulase, hemicellulose, polysaccharidase, xylan.
effects, not only by promoting substrate attachment, but also by disrupting the structure of the cellulose surface, making the microfibrils more accessible to enzyme attack [13, 14] . The observation that the type III CBD of the Clostridium cellulo orans cellulosome integrating protein A (CipA) also potentiates cellulase activity, when not covalently attached to these enzymes, indicates that this domain may also mediate its effect, at least in part, by a disruptive mechanism [15] . In contrast, two Pseudomonas Type II CBDs did not appear to disrupt the structure of cotton, and only potentiated cellulase and xylanase activities when covalently attached to these enzymes [10] . These data suggest that the Pseudomonas Type II CBDs elevate enzyme activity simply by increasing the effective concentration of these biocatalysts on the surface of the recalcitrant substrate. Aerobic-bacterial plant-cell-wall hydrolases often contain duplicated CBD sequences [16, 17] . This feature is exemplified by Pseudomonas fluorescens subsp. cellulosa plant-cell-wall hydrolases which generally consist of a catalytic domain and a Type II CBD, separated by a highly conserved small 40-residue noncatalytic domain [18] [19] [20] [21] which shows strong sequence similarity to the C-terminal Type X CBD of Pseudomonas xylanase E [22] . Although the Type X CBD is functional in xylanase E (the enzyme contains no other CBDs except the Type X domain) ; in the Pseudomonas enzymes that contain multiple CBDs, it is currently unclear whether both the Type II and Type X domains retain their capacity to bind to cellulose.
Although multiple sequences that exhibit similarity to CBDs are a relatively common phenomenon among bacterial plant-cellwall hydrolases [16, 21] , the selection pressures that have led to their evolution are not readily apparent. In this paper we have analysed the biological significance of the Type X CBD (CBD X ) of xylanase A (Pf Xyn10A) from P. fluorescens subsp. cellulosa, which also contains an N-terminal Type II CBD, an internal Type X CBD homologue (CBD X ) and a C-terminal glycosyl hydrolase family 10 xylanase catalytic domain [21, 23] . In this report we show that CBD X binds to cellulose, with an affinity approximately six times lower than the Type II domain, and that it potentiates Pf Xyn10A activity against insoluble complex substrates by increasing enzyme substrate proximity alone, rather than through the additional mechanism of disruption of the cellulose structure. CBD X does not appear to interact synergistically with the Type II domain in full-length Pf Xyn10A, either in ligand binding or in the potentiation of catalytic activity. The functional significance of CBD X in Pf Xyn10A is discussed.
MATERIALS AND METHODS

Bacterial strains, plasmids and culture conditions
The Escherichia coli strains used in this study were BL21(DE3) : pLysS (Novagen, Madison, WI, U.S.A.), JM83 [24] and XL1-Blue (Stratagene). The plasmid vectors employed in this study were pCR-Blunt (Invitrogen) and pET16b (Novagen). Plasmid pRS4, which encodes the catalytic domain of Pf Xyn10A (Pf Xyn10A CD ), was described previously [23] . Plasmids constructed during the course of this study are denoted as follows : pJG1, encoding the mature Pf Xyn10A ; pJG2, encoding the Type X CBD homologue from Pf Xyn10A (CBD X ) ; pJG3, encoding a truncated version of Pf Xyn10A (Pf Xyn10Ah) comprising the catalytic domain and Type X CBD, but lacking the Type II CBD ; pJG4, encoding a catalytically inactive mutant of Pf Xyn10Ah (E246A) in which the catalytic nucleophile, Glu-246, was mutated to an alanine residue ; pJG5, encoding a truncated version of Pf Xyn10A (Pf Xyn10Ahh) lacking the Type X CBD, in which the Type II CBD and catalytic domain of the enzyme are joined by a serine-rich linker sequence. The molecular architectures of the proteins used in this study are displayed in Figure 1 . All E. coli strains were cultured in Luria broth (LB) supplemented with ampicillin (50 µg\ml). To produce Pf
Figure 1 Molecular architecture of Pf Xyn10A and its derivatives
The domains present in the derivatives of PF Xyn10A are represented as follows : Type II CBD ( ), Type X CBD ( ) and the catalytic domain (CD) ( ). Linker sequences are depicted by a heavy bold line. The plasmid pJG4 encodes Pf Xyn10Ah in which the catalytic nucleophile of the catalytic domain (Glu-246) has been mutated to an alanine. This protein is referred to as E246A.
Xyn10A CD , E. coli XL1-Blue harbouring pRS4 was grown for 16 h at 37 mC in LB containing ampicillin. To generate the other recombinant proteins E. coli BL21(DE3), harbouring pLysS and the appropriate recombinant plasmids, was cultured to midexponential phase (D &&! 0.5) in LB containing ampicillin at 37mC. Isopropylthio-β--galactopyranoside was then added to a final concentration of 1 mM and the cultures were incubated for a further 4 h at 30 mC.
Construction of plasmids
The plasmids pJG1, pJG2, pJG3 and pJG5 were constructed by using PCR to amplify regions of the gene (xynA) flanked by appropriate restriction sites, and inserting the resultant DNA into pET expression vectors. The primer pairs and the amplified regions of xynA are displayed in Table 1 . The blunt-ended PCR products were ligated into pCR-Blunt, and selected transformants were sequenced using a 373 Applied Biosystems (Foster City, CA, U.S.A.) sequenator and the Dye Prism dideoxy terminator kit (Applied Biosystems). The xynA sequences were then excised from the recombinant plasmids by digestion with NdeI and BamHI and cloned into pET16b to generate pJG1, pJG2 and pJG3. To construct pJG5, the region of xynA between nucleotides 78 and 538, encoding the Type II CBD of Pf Xyn10A and the upstream 45-residue-linker sequence, was amplified and the resultant PCR product cloned into pET16b which had been cut with NdeI and BamHI to generate pJG5h. The region of xynA between nucleotides 779 and 1832, encoding the catalytic domain of Pf Xyn10A, was amplified with primers that incorporated BamHI sites at the 5h and 3h ends of the PCR product. The resultant DNA was then cloned into the BamHI site of pJG5h, and recombinants in which the two regions of xynA were in the same orientation were designated pJG5, and retained for further use. The conditions used in all the PCR reactions were as described previously [25] . The plasmid pJG4 was constructed by subjecting pJG2 to site-directed mutagenesis using the Transformer kit supplied by ClonTech (Heidelberg, Germany). The selection and mutagenic primers used in the Transformer method were 5h-GACTGGTGAGTATTCAACCAAGTC-3h and 5h-AC-GCACATCCAATGCAGTAATCTTGAT-3h, respectively. The nucleotides in bold are the mutations incorporated into xynA.
Purification of recombinant proteins
Pf Xyn10A CD was purified by anion-exchange chromatography as described previously [21] . CBD X , Pf Xyn10A, Pf Xyn10Ah, E246A and Pf Xyn10Ahh all contained N-terminal His "! tags, and were therefore purified by nickel-ion-affinity chromatography, using a Talon4 metal-affinity column (ClonTech). The purification protocols were as described previously [10] .
Enzyme, ligand and protein assays
The activities of Pf Xyn10A and its derivatives against soluble xylan, methylumbelliferyl-β--cellobioside (MUC) and cellulose-xylan complexes were determined as described previously [12] . Protein concentration was determined by the method of Pace et al. [26] and the purity of protein preparations was evaluated by SDS\PAGE [27] . Affinity-gel electrophoresis was performed essentially as described by Tomme et al. [28] . Release of carbohydrate from cotton fibres was determined by the phenol\sulphuric acid method of Dubois et al. [29] , and the binding of the Type X CBD and full length Pf Xyn10A to different forms of cellulose was performed as described by Bolam et al. [10] . Type X cellulose-binding domains Pf Xyn10Ah 5h-GCGACACCCGGCTCGCATATGGGTAACCAGCAATGTA-3h 5h-GCGGGATCTTAACGACCACTCAATGCCTCGAC-3h 536-1832 pJG5
Pf Xyn10Ahh 5h-GGCAGATCTGCATATGGCACAAACAGCAACCTTGC-3h 5h-CGCGGATCCCTGGACGAGCCGGGTGTACTGCTGGC-3h 78-538 5h-GCGGATCCTGCCACCGGCAACGGTTTGGCCAGCC-3h 5h-GCGGGATCTTAACGACCACTCAATGCCTCGAC-3h 779-1832
Figure 2 SDS/PAGE of purified Pf Xyn10A and its derivatives
The purified proteins were subjected to SDS/PAGE using a 10 % acrylamide gel. 
Biophysical properties of cellulose and plant cell walls
Evaluation of microfibril release from cotton by the Type X CBD was as described previously [10] . The capacity of CBD X to influence the extensibility of plant cell walls was determined by measuring the rate at which the plant cell wall is extended when subjected to a constant force (Creep assay) as described previously [10] , and the influence of the protein on the tensile strength of filter paper was assessed using an Instron 91-51-17M extensometer (Instron, Boston, MA, U.S.A.), as described by Bolam et al. [10] .
Figure 3 The capacity of Pf Xyn10Ah and Pf Xyn10A CD to bind to Avicel
Pf Xyn10Ah and Pf Xyn10A CD were incubated with Avicel and the capacity of the proteins to bind to the polysaccharide was evaluated by SDS/PAGE using a 10 % acrylamide gel. 
NMR spectroscopy
NMR spectroscopy of CBD X was performed as described previously [10] .
RESULTS
The internal domain of Pf Xyn10A is a functional CBD
To establish whether the internal CBD X homologue of Pf Xyn10A is functional, we purified Pf Xyn10Ah, which lacks the Nterminal Type II CBD (Figures 1 and 2) , and the catalytic domain of the enzyme (Pf Xyn10A CD ), and incubated the proteins with cellulose. The data ( Figure 3) showed that Pf Xyn10Ah bound to Avicel, whereas Pf Xyn10A CD did not interact with the insoluble matrix. These results demonstrate that the internal domain of Pf Xyn10A is a functional Type X CBD.
Cellulose-binding properties of CBD X
The affinities of Pf Xyn10Ah and CBD X , expressed as a discrete domain, for different forms of cellulose were analysed by bindingisotherm measurements using the model described previously [30] . A typical example of the data obtained is displayed in Figure 4 . The results, which seemed to fit a one-site binding model, were used to calculate the affinity constant for binding to cellulose. The data (Table 2) showed that Pf Xyn10Ah and CBD X exhibited similar affinities for acid-swollen cellulose and bacterial microcrystalline cellulose, which were approximately six-fold lower than the affinity of the Pf Xyn10A Type II CBD for the corresponding ligands [10] . To investigate whether CBD X exhibits any affinity for soluble cellulose derivatives, Pf Xyn10Ah was subjected to nondenaturing gel electrophoresis in the presence and absence of hydroxyethyl-cellulose. There was no apparent retardation in the electrophoretic mobility of the enzyme when the soluble cellulose was added to the matrix (results not shown). In addition, there Type X cellulose-binding domains was no significant difference in the binding of CBD X to bacterial microcrystalline cellulose in the presence of cellohexaose, and the oligosaccharide did not elute the domain from insoluble cellulose, even at saturating sugar concentrations (results not shown). Analysis of the NMR spectrum of CBD X , titrated with increasing concentrations of cellohexaose, showed that there was a small downfield shift in two of the Trp N ε H signals, and a similar shift in an Ile signal ( Figure 5 ). The affinity constant for the binding was estimated from a plot of the change in chemical shift of the γ carbon of Ile-51 against ligand concentration using the method described by Johnson et al. [6] . The results (Figure 6) showed that the K a value for cellohexaose was approximately 1.1i10# M −" . It is apparent, therefore, that the affinity of the CBD for cellohexaose was approx. 2500 times as low as for insoluble cellulose. These results show that CBD X , like many other CBD families [4, 10] , binds much more tightly to insoluble cellulose than to soluble forms of the polysaccharide or cellooligosaccharides, suggesting that the domain interacts with more than one cellulose chain within the crystalline lattice.
To establish whether Type II and Type X CBDs act in synergy to bind to cellulose in full length Pf Xyn10A, the wild-type Pf Xyn10A was purified ( Figure 2 ) and its affinity for different forms of cellulose was evaluated. The data displayed in Table 2 showed that native Pf Xyn10A and the Type II CBD of the xylanase exhibited very similar affinities for cellulose, indicating that there is no synergy in ligand binding between the two CBDs in Pf Xyn10A.
Does CBD X potentiate catalytic activity ?
To establish whether CBD X potentiates xylanase activity against cellulose-xylan complexes, Pf Xyn10A, Pf Xyn10Ah, Pf Xyn10Ahh and Pf Xyn10A CD were incubated with the insoluble cellulosexylan complex, soluble xylan and MUC, and the capacity of the three enzymes to hydrolyse these substrates was assessed. When the four enzymes were incubated with the cellulose-xylan complex, more than 99 % of Pf Xyn10A CD was not associated with the insoluble polysaccharide complex during the experiment, while 90 % of Pf Xyn10A, Pf Xyn10Ah and Pf Xyn10Ahh bound to the cellulose-xylan complex, and there was no substantial decrease in the activity of the enzymes during the course of the experiment (results not shown). The activities of the four enzymes against the three substrates are displayed in Table 3 and Figure 7 . All the enzymes exhibited similar activities against soluble xylan or MUC ; however, Pf Xyn10A, Pf Xyn10Ah and Pf Xyn10Ahh were 2.5 times more active against the xylan-cellulose complex than Pf Xyn10A CD . These data indicate that CBD X potentiates xylanase activity against insoluble cellulose-xylan complexes, but not against soluble substrates that contain no cellulose.
Does CBD X disrupt plant cell wall structure ?
To investigate whether CBD X disrupts the structure of the plant cell wall and crystalline cellulose, the domain was incubated with
Figure 6 Plot of change in the chemical shift of the NMR spectrum against cellohexaose concentration
The change in chemical shift was for the protons attached to the γ carbon of Ile-51. The data in this figure are derived from the NMR spectra shown in Figure 5 . plant cell walls derived from cucumber hypocotyls and with Whatman 3MM filter paper strips, and its effect on the integrity of these macromolecules was monitored by the Creep and the Instron assays. CBD X did not affect the extensibility of plant cell walls when exposed to a constant force (Creep assay), or decrease the load required to break paper strips in the Instron assay (results not shown). To further investigate whether CBD X can disrupt crystalline cellulose, the domain was incubated with cotton fibres and the release of microfibrils was monitored. No release of small particles from the cotton was observed (data not shown). The Creep, Instron and small-particle-release assays indicated that CBD X does not cause a substantial disruption of cellulose or the plant cell wall. To investigate whether CBD X could be influencing the activity of Pf Xyn10A against the cellulose-xylan complex by increasing substrate accessibility, Pf Xyn10A CD was incubated with the Pf Xyn10A (4), Pf Xyn10Ah (>), Pf Xyn10Ahh (X) and Pf Xyn10A CD () were incubated with cellulose-xylan complex derived from kraft pulp. The release of reducing sugar was determined as described in the Materials and methods section. Table 4 The activity of Pf Xyn10A CD with the cellulose-xylan complex in the presence of CBD X and E246A a CBD refers to either CBD X or E246A, which were added to the enzyme reactions containing Pf Xyn10A CD .
b Catalytic activity is relative to the activity of Pf Xyn10A CD with the cellulose-xylan complex in the absence of CBD X or E246A. When tested at a concentration equivalent to that in the 10 : 1 ratio, CBD X and E246A had no measurable activity in the absence of Pf Xyn10A CD . polysaccharide matrix in the presence of increasing concentrations of CBD X or E246A. The data, presented in Table 4 , showed that the CBD did not potentiate the activity of Pf Type X cellulose-binding domains Xyn10A CD . These data suggest that CBD X does not mediate its positive effect on Pf Xyn10A catalytic activity by disrupting the structure of the cellulose component of the target substrates.
DISCUSSION
Results presented in this study show that CBD X binds to different forms of insoluble cellulose, although its affinity for these ligands is approximately six-fold lower than that of the Type II CBD from the same enzyme. These results support the view that, in Pseudomonas enzymes containing Types II and X CBDs, both domains retain the capacity to bind to insoluble cellulose. In contrast, CBD X did not interact with soluble cellulose and exhibited very weak affinity for cello-oligosaccharides. This high degree of ligand specificity for insoluble cellulose also occurs in Types I, II and III CBDs [4, 5, 10] , but not in Type IV CBDs [6, 28] . Those domains that exhibit a preference for insoluble cellulose contain a planar hydrophobic face, rich in aromatic residues, that constitutes the ligand-binding region of these proteins. In view of the preference of CBD X for insoluble cellulose, we suggest that the ligand-binding region of this domain will also contain a planar surface of exposed aromatic residues. Precisely why these CBDs exhibit a preference for insoluble cellulose is, currently, unclear, although it is likely that the ligand specificity of these domains is related to their capacity to bind to multiple cellulose chains. It is interesting to note that the molecular architecture of Pf Xyn10A is common to other Pseudomonas plant-cell-wall hydrolases, with three cellulases, a cellodextrinase and a mannanase all consisting of a Type II CBD, Type X CBD and a catalytic domain [18] [19] [20] [21] . Based on the results presented in this report, we suggest that in all these enzymes both the Type II and Type X CBDs retain their capacity to bind to cellulose. The affinity of full-length Pf Xyn10A for cellulose is very similar to the affinity of the enzyme's Type II CBD, suggesting that no significant synergy is observed between the two CBDs of the xylanase. Linder et al. [31] showed that extensive synergy occurred between two Type I CBDs (similar cellulose affinity to CBD X ) when they were covalently linked to form a single polypeptide. In contrast, tandem repeats of the relatively weak Type IV CBD from C. fimi endo-β-1,4-glucanase C (CenC) did not exhibit higher affinity for cellulose compared with the CBDs expressed as discrete entities. It would appear, therefore, that multiple CBDs in single enzymes do not cause a substantial increase in affinity for cellulose, and we suggest that the evolutionary rationale for having both Type II and Type X CBDs in several Pseudomonas plant-cell-wall hydrolases is not to increase the enzymes' affinity for cellulose.
In a previous study we showed that the Type II CBD of Pf Xyn10A potentiated the activity of the enzyme against complex substrates [12] . Results presented in this study showed that CBD X increased the activity of Pf Xyn10A against an insoluble cellulose-xylan complex, but not against soluble xylan or MUC. These results indicate that both the Type II and Type X CBDs in Pf Xyn10A play an important role in the activity of the enzyme against plant cell walls. These observations raise the possibility that the Type II and Type X CBDs of Pf Xyn10A act synergistically to potentiate the activity of the enzyme against the cellulose-xylan complex. However, as Pf Xyn10A, Pf Xyn10Ah and Pf Xyn10Ahh exhibited similar activities against cellulosexylan complexes, there is no evidence to suggest that multiple CBDs are more effective in potentiating the activity of Pf Xyn10A against complex substrates than single CBDs, regardless of whether they are Type II or Type X.
Previously we have shown that Pseudomonas Type II CBDs do not affect the structural integrity of either cellulose or plant cell walls, and thus do not potentiate cellulase and xylanase activity by increasing the accessibility of the substrate [10] . The results in the present report also showed that CBD X did not disrupt the structure of either cellulose or the plant cell wall. It could be argued that the biophysical measurements used here only detect substantial changes in the structure of these macromolecules, and if CBD X caused only subtle changes in the structure of cellulose and\or the plant cell wall, they would not be detected by the Creep and Instron assays. Indeed, it has been suggested [14] that Cellulomonas Type II CBDs only cause very small changes to the structure of crystalline cellulose, such as the solvation of single cellulose chains at the surface of the microfibrils, and it is possible that these effects on the structure of these macromolecules would not be detected by the biophysical measurements used in the present study. However, if CBD X was potentiating xylanase activity by increasing the accessibility of the substrate via a disruptive mechanism, then the domain should be capable of increasing the activity of Pf Xyn10A CD especially at high CBD X :Pf Xyn10A CD ratios, even when it is not covalently attached to the enzyme. The results presented in this study showed that CBD X , when it was not covalently attached to Pf Xyn10A CD , did not influence the capacity of the enzyme to attack the insoluble cellulose-xylan complex. This behaviour argues against the possibility that the domain is potentiating xylanase activity by disrupting the structure of the substrate and thus making the target bonds more accessible to enzyme attack. We propose, therefore, that CBD X , by bringing Pf Xyn10A into prolonged contact with the plant cell wall, increases the effective concentration of the enzyme on the surface of the substrate, thereby facilitating an increase in glycosidic-bond cleavage.
To conclude, the results presented in this report show that the Type X CBD homologue in Pf Xyn10A binds to cellulose and, like many other types of CBD, exhibits a strong preference for insoluble forms of the polysaccharide. CBD X enhances the activity of Pf Xyn10A by increasing the enzyme concentration on the surface of the substrate, rather than improving the accessibility of the target glycosidic bonds by disrupting the structure of the plant cell wall. No synergy was observed, either in ligand binding or in the potentiation of catalytic activity, between the Type II and Type X CBDs in Pf Xyn10A. It is difficult, therefore, to understand the selection pressure(s) that have led to the evolution of several Pseudomonas plant-cell-wall hydrolases which contain two distinct CBDs that are both functional. It could be argued that these enzymes recently acquired a module consisting of a Type II and Type X CBD, and that there has not been sufficient time for mutations to accumulate that result in loss of function of either of these domains. We believe that this is very unlikely as the linker sequences between the Type II and Type X CBDs in the Pseudomonas cellulases, xylanases and mannases are different in sequence and length, suggesting either : (i) that several different recombination events led to the evolution of modules comprising Type II and Type X CBDs, or (ii) that there was a single module consisting of the Type II and Type X domains, which has acquired numerous mutations in the linker regions. We propose that although both domains bind to similar cellulose molecules, the two CBDs can bind to different forms of cellulose within the context of the plant cell wall. For example, maybe the Type II CBD binds to cellulose that is H-bonded with xylans, whereas the Type X domain binds preferentially to cellulose microfibrils that interact with xyloglucans. Future work will be directed towards investigating whether the different types of CBD exhibit preference for cellulose molecules that interact with specific hemicellulose molecules within the plant cell wall.
